I

Immuneering Corp
NASDAQ:IMRX

Watchlist Manager
Immuneering Corp
NASDAQ:IMRX
Watchlist
Price: 2.1 USD -0.47% Market Closed
Market Cap: 62.3m USD
Have any thoughts about
Immuneering Corp?
Write Note

Balance Sheet

Balance Sheet Decomposition
Immuneering Corp

Current Assets 89.1m
Cash & Short-Term Investments 85.7m
Other Current Assets 3.4m
Non-Current Assets 13.5m
PP&E 5.4m
Intangibles 7.1m
Other Non-Current Assets 1m
Current Liabilities 7.8m
Accounts Payable 2.1m
Accrued Liabilities 5.5m
Other Current Liabilities 259.8k
Non-Current Liabilities 4.2m
Other Non-Current Liabilities 4.2m

Balance Sheet
Immuneering Corp

Rotate your device to view
Balance Sheet
Currency: USD
Dec-2019 Dec-2020 Dec-2021 Dec-2022 Dec-2023
Assets
Cash & Cash Equivalents
14
37
75
73
59
Cash Equivalents
14
37
75
73
59
Short-Term Investments
0
0
74
33
26
Total Receivables
0
1
0
0
0
Accounts Receivables
0
1
0
0
0
Other Receivables
0
0
0
0
0
Other Current Assets
0
0
3
3
3
Total Current Assets
14
38
152
109
89
PP&E Net
0
1
6
6
5
PP&E Gross
0
1
6
6
5
Accumulated Depreciation
0
0
0
0
1
Intangible Assets
0
0
0
0
0
Goodwill
0
0
7
7
7
Long-Term Investments
0
0
1
0
0
Other Long-Term Assets
0
0
0
1
1
Other Assets
0
0
7
7
7
Total Assets
14
N/A
38
+172%
167
+334%
122
-27%
103
-16%
Liabilities
Accounts Payable
0
2
1
3
2
Accrued Liabilities
0
1
4
5
5
Short-Term Debt
0
0
0
0
0
Other Current Liabilities
0
0
0
0
0
Total Current Liabilities
1
2
6
8
8
Long-Term Debt
0
0
0
0
0
Other Liabilities
4
1
5
5
4
Total Liabilities
4
N/A
3
-30%
11
+282%
13
+17%
12
-4%
Equity
Common Stock
17
58
0
0
0
Retained Earnings
9
26
59
110
163
Additional Paid In Capital
2
3
215
220
254
Other Equity
0
0
0
0
0
Total Equity
10
N/A
36
+252%
156
+338%
110
-30%
91
-18%
Total Liabilities & Equity
14
N/A
38
+172%
167
+334%
122
-27%
103
-16%
Shares Outstanding
Common Shares Outstanding
24
24
26
26
29

See Also

Discover More